Best Cannabis Stocks To Consider - August 30th

Key Points

• The article highlights five cannabis stocks to consider, including Canopy Growth, Tilray Brands, and Incannex Healthcare, all of which have shown significant trading volume recently.
• Canopy Growth focuses on cannabis production across multiple segments, while Tilray Brands specializes in medical cannabis research and distribution worldwide.
• Incannex Healthcare is involved in the development of medicinal cannabinoid products, targeting various medical conditions, showcasing the diverse applications of cannabis in the healthcare sector.

Canopy Growth, Tilray Brands, Incannex Healthcare, Indivior, and Turning Point Brands are the five Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are shares of publicly traded companies involved in the cultivation, processing, distribution and sale of cannabis and related products. By buying these shares, investors gain exposure to the legal cannabis industry’s growth prospects as well as its regulatory and market risks. Their performance is influenced by factors such as changes in legislation, consumer demand and competitive dynamics within the sector. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.

Canopy Growth (CGC)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

Read Our Latest Research Report on CGC

Tilray Brands (TLRY)

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

Read Our Latest Research Report on TLRY

Incannex Healthcare (IXHL)

Incannex Healthcare Inc., a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.

Read Our Latest Research Report on IXHL

Indivior (INDV)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

Read Our Latest Research Report on INDV

Turning Point Brands (TPB)

Turning Point Brands, Inc., together with its subsidiaries, manufactures, markets, and distributes branded consumer products. The company operates through three segments: Zig-Zag Products, Stoker's Products, and Creative Distribution Solutions. Zig-Zag Products segment markets and distributes rolling papers, tubes, finished cigars, make-your-own cigar wraps, and related products, as well as lighters and other accessories under the Zig-Zag brand.

Read Our Latest Research Report on TPB

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.